232
Participants
Start Date
December 14, 2020
Primary Completion Date
January 15, 2025
Study Completion Date
August 26, 2026
Rilzabrutinib
400mg Caplet
Placebo
400mg Caplet
Investigational Site Number : 34803, Budapest
Investigational Site Number : 4002, Vienna
Investigational Site Number : 57801, Grålum
Investigational Site Number : 3608, Westmead
Investigational Site Number : 3607, Kogarah
Investigational Site Number : 3606, Frankston
Investigational Site Number : 34805, Debrecen
Investigational Site Number : 3611, Brisbane
Investigational Site Number : 4003, Steyr
Investigational Site Number : 34804, Nyíregyháza
Investigational Site Number : 3609, Adelaide
Investigational Site Number : 57802, Bergen
Investigational Site Number : 3208, San Juan
Investigational Site Number : 3610, Perth
Investigational Site Number : 34802, Székesfehérvár
Investigational Site Number : 4005, Graz
Investigational Site Number : 4004, Leoben
Investigational Site Number : 34801, Győr
Investigational Site Number : 27610, Berlin
Investigational Site Number : 76405, Bangkok
Investigational Site Number : 76404, Bangkok
Montefiore Medical Center_Investigational Site Number 84032, The Bronx
Investigational Site Number : 41001, Suwon
The Children's Hospital of Philadelphia (CHOP)_Investigational Site Number 84027, Philadelphia
Investigational Site Number : 38015, Milan
Investigational Site Number : 38013, Milan
Investigational Site Number : 25010, Dijon
Investigational Site Number : 72410, Madrid
Investigational Site Number : 72408, Málaga
Investigational Site Number : 72411, Murcia
Children's Healthcare of Atlanta_Investigational Site Number 84034, Atlanta
Investigational Site Number : 48402, Chihuahua City
Investigational Site Number : 25007, Pessac
Investigational Site Number : 48404, Durango
Investigational Site Number 79210, Istanbul
Investigational Site Number : 38010, Trieste
ASCLEPES Research Centers_Investigational Site Number 84023, Weeki Wachee
Investigational Site Number 79206, Izmir
Investigational Site Number : 38011, Vicenza
Investigational Site Number 79209, Kayseri
Investigational Site Number : 76401, Khon Kaen
Investigational Site Number : 38012, Bologna
University of Louisville - James Graham Brown Cancer Center_Investigational Site Number 84033, Louisville
Investigational Site Number 27612, Düsseldorf
Investigational Site Number : 72413, Seville
Investigational Site Number : 25009, Nantes
University Hospitals Cleveland Medical Center Site Number : 84036, Cleveland
Cleveland Clinic_Investigational Site Number 84026, Cleveland
Investigational Site Number : 48403, Zapopan
Investigational Site Number : 27611, Recklinghausen
Investigational Site Number : 72407, Valencia
Investigational Site Number : 80408, Dnipropetrovsk
Investigational Site Number : 41004, Busan
Investigational Site Number : 25014, Angers
Investigational Site Number : 80409, Kryvyi Rih
Investigational Site Number : 38014, Florence
Investigational Site Number : 76402, Chiang Mai
Investigational Site Number : 37608, Tel Litwinsky
Investigational Site Number : 27613, Frankfurt am Main
Rush University Medical Center_Investigational Site Number 84029, Chicago
Investigational Site Number : 15613, Tangshan
Investigational Site Number : 48401, Monterrey
Investigational Site Number : 37609, Ẕerifin
Investigational Site Number : 25008, Paris
Investigational Site Number : 25012, Paris
Children's Hospital Colorado_Investigational Site Number 84025, Aurora
IMMUNOe International Research Centers_Investigational Site Number 84028, Centennial
University of Utah-Huntsman Cancer Institute_Investigational Site Number 84035, Salt Lake City
University of Southern California_Investigational Site Number 84024, Los Angeles
Investigational Site Number : 76403, Songkhla
Lundquist Institute for Biomedical Innovation at Harbor UCLA Medical Center_Investigational Site Number 84037, Torrance
The Oncology Institute of Hope and Innovation_Investigational Site Number 84031, Whittier
Investigational Site Number : 25011, Créteil
UCSF Benioff Children's Hospital San Francisco_Investigational Site Number 84020, San Francisco
University of Washington Medical Centre Site Number : 84041, Seattle
Shengjing Hospital of China Medical University - Investigational Site Number: 15603, Shenyang
Investigational Site Number : 64307, Moscow
Investigational Site Number : 70201, Singapore
Investigational Site Number : 64305, Moscow
Investigational Site Number : 70202, Singapore
Investigational Site Number : 64302, Saint Petersburg
Investigational Site Number : 15614, Zhenjiang
Investigational Site Number : 15609, Wuxi
Qilu Hospital of Shandong University - Investigational Site Number: 15605, Jinan
Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences - Investigational Site Number: 15602, Tianjin
Investigational Site Number : 64303, Tula
Investigational Site Number : 70203, Singapore
Investigational Site Number : 15611, Hangzhou
Investigational Site Number : 15202, Viña del Mar
Investigational Site Number : 15610, Nanchang
Investigational Site Number : 64301, Pyatigorsk
Wuhan Union Hospital of Tongji Medical College of HUST - Investigational Site Number: 15601, Wuhan
Investigational Site Number : 64306, Samara
Investigational Site Number : 64304, Novosibirsk
Second Affiliated Hospital of Kunming Medical University - Investigational Site Number: 15604, Kunming
Shaanxi Provincial People's Hospital - Investigational Site Number: 15607, Xi'an
Investigational Site Number : 15201, La Serena
Investigational Site Number : 37605, Haifa
Investigational Site Number : 37606, Kfar Saba
Investigational Site Number : 37607, Tel Aviv
Investigational Site Number : 15204, Santiago
HEMORIO - Instituto Estadual de Hematologia Arthur de Siqueira Cavalcanti Site Number : 7609, Rio de Janeiro
Hospital Sao Rafael Instituto D'Or da Bahia Site Number : 7608, Salvador
Massachusetts General Hospital Site Number : 84038, Boston
Investigational Site Number : 3206, Capital Federal
Investigational Site Number : 3211, La Plata
Investigational Site Number : 3205, Córdoba
Investigational Site Number : 3209, Corrientes
Investigational Site Number : 4001, Linz
Uniao Oeste Paranaense de Estudos e Combates ao Cancer Site Number : 7610, Cascavel
Hospital De Clinicas De Porto Alegre Site Number : 7605, Porto Alegre
Hospital Santa Marcelina Site Number : 7611, São Paulo
CEMEC Oncologica do Brasil Site Number : 7606, Belém
Hospital do Servidor Publico Estadual de Sao Paulo Site Number : 7607, São Paulo
Investigational Site Number : 12404, Edmonton
Investigational Site Number : 12406, Toronto
CHU Sainte-Justine_Investigational site number 12405, Montreal
Investigational Site Number : 15608, Hefei
Investigational Site Number : 39214, Tsuchiura-shi
Investigational Site Number : 72416, Burgos
Investigational Site Number : 39205, Kanazawa
Investigational Site Number : 39207, Sagamihara-shi
Investigational Site Number : 39202, Suita-shi
Investigational Site Number : 39201, Iruma-gun
Investigational Site Number : 39208, Bunkyo-ku
Investigational Site Number : 39210, Meguro-ku
Investigational Site Number : 39204, Setagaya City
Investigational Site Number : 39209, Sumida-ku
Investigational Site Number : 39212, Chiba
Investigational Site Number : 39203, Hiroshima
Investigational Site Number : 39206, Saitama-shi
Investigational Site Number : 48405, Delegacion Benito Juarez
Investigational Site Number : 48406, Mexico City
Erasmus MC_Investigational Site Number 52801, Rotterdam
Investigational Site Number : 61617, Piła
Investigational Site Number : 61609, Słupsk
Investigational Site Number : 61615, Gdynia
Investigational Site Number : 61614, Poznan
Investigational Site Number : 61612, Warsaw
Investigational Site Number : 61613, Wroclaw
Investigational Site Number : 41003, Seoul
Investigational Site Number : 41005, Seoul
Investigational Site Number : 41006, Seoul
Investigational Site Number : 72412, Barcelona
Investigational Site Number : 72414, Barcelona
Investigational Site Number : 72409, Barcelona
Investigational Site Number 79208, Ankara
Investigational Site Number : 80410, Kyiv
Investigational Site Number : 82607, London
Investigational Site Number : 82604, Harrow
Investigational Site Number : 82606, London
Investigational Site Number : 82609, London
Investigational Site Number : 82603, Manchester
Investigational Site Number : 82605, Norfolk
Investigational Site Number : 82608, Southampton
Principia Biopharma, a Sanofi Company
INDUSTRY